| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 26/06/2017 | 22:17 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | NASDAQ:GNVC | Genvec, Inc. |
| 20/06/2017 | 22:38 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GNVC | Genvec, Inc. |
| 16/06/2017 | 17:08 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:GNVC | Genvec, Inc. |
| 16/06/2017 | 16:34 | Edgar (US Regulatory) | Withdrawal of Registration Statement (rw) | NASDAQ:GNVC | Genvec, Inc. |
| 16/06/2017 | 16:15 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:GNVC | Genvec, Inc. |
| 16/06/2017 | 15:15 | PR Newswire (US) | Intrexon Integrates Leading Adenoviral Gene Delivery Technology with Completion of GenVec Acquisition | NASDAQ:GNVC | Genvec, Inc. |
| 16/06/2017 | 15:09 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:GNVC | Genvec, Inc. |
| 12/05/2017 | 22:37 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:GNVC | Genvec, Inc. |
| 10/05/2017 | 22:19 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:GNVC | Genvec, Inc. |
| 24/04/2017 | 01:35 | PR Newswire (US) | Act Now - Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of GenVec, Inc. - GNVC | NASDAQ:GNVC | Genvec, Inc. |
| 14/03/2017 | 22:29 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:GNVC | Genvec, Inc. |
| 14/03/2017 | 21:21 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:GNVC | Genvec, Inc. |
| 06/03/2017 | 22:32 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:GNVC | Genvec, Inc. |
| 01/03/2017 | 23:10 | PR Newswire (US) | Intrexon Announces Fourth Quarter and Full Year 2016 Financial Results | NASDAQ:GNVC | Genvec, Inc. |
| 16/02/2017 | 22:37 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:GNVC | Genvec, Inc. |
| 09/02/2017 | 00:56 | PR Newswire (US) | WeissLaw LLP: GenVec, Inc. Acquisition May Not Be in the Best Interests of GNVC Shareholders | NASDAQ:GNVC | Genvec, Inc. |
| 24/01/2017 | 22:57 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:GNVC | Genvec, Inc. |
| 24/01/2017 | 22:07 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:GNVC | Genvec, Inc. |
| 24/01/2017 | 15:00 | PR Newswire (US) | Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform | NASDAQ:GNVC | Genvec, Inc. |
| 11/01/2017 | 14:00 | PR Newswire (US) | GenVec to Present at Phacilitate Cell & Gene Therapy World 2017 | NASDAQ:GNVC | Genvec, Inc. |
| 01/12/2016 | 13:00 | PR Newswire (US) | GenVec Effects 1-for-10 Reverse Stock Split | NASDAQ:GNVC | Genvec, Inc. |
| 04/11/2016 | 12:30 | PR Newswire (US) | GenVec Reports Third Quarter 2016 Financial Results | NASDAQ:GNVC | Genvec, Inc. |
| 28/09/2016 | 14:00 | PR Newswire (US) | GenVec To Present At 2016 Cell & Gene Meeting On The Mesa | NASDAQ:GNVC | Genvec, Inc. |
| 12/09/2016 | 18:22 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:GNVC | Genvec, Inc. |
| 02/09/2016 | 22:07 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:GNVC | Genvec, Inc. |
| 26/08/2016 | 22:16 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | NASDAQ:GNVC | Genvec, Inc. |
| 05/08/2016 | 13:30 | PR Newswire (US) | GenVec Reports Second Quarter 2016 Financial Results | NASDAQ:GNVC | Genvec, Inc. |
| 25/07/2016 | 13:30 | PR Newswire (US) | FDA Lifts Clinical Hold On CGF166 | NASDAQ:GNVC | Genvec, Inc. |
| 12/05/2016 | 14:00 | PR Newswire (US) | GenVec Reports First Quarter 2016 Financial Results | NASDAQ:GNVC | Genvec, Inc. |
| 06/05/2016 | 23:57 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | NASDAQ:GNVC | Genvec, Inc. |